Mutations in PTPN11 are found commonly in JMML patients without RAS and NF1 mutation and are involved in leukemiogenesis by negative regulation of the RAS pathway by conferring growth advantage [45]. Here, PTPN11 is linked to juvenile myelomonocytic leukemia.